QuidelOrtho ROE 2010-2025 | QDEL
Current and historical return on equity (ROE) values for QuidelOrtho (QDEL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| QuidelOrtho ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-06-30 | $-0.47B | $2.79B | -15.58% |
| 2025-03-31 | $-0.36B | $3.00B | -11.63% |
| 2024-12-31 | $-2.05B | $2.99B | -64.86% |
| 2024-09-30 | $-1.87B | $3.19B | -50.89% |
| 2024-06-30 | $-1.86B | $3.17B | -45.21% |
| 2024-03-31 | $-1.77B | $3.31B | -38.61% |
| 2023-12-31 | $-0.01B | $5.01B | -0.20% |
| 2023-09-30 | $0.01B | $4.97B | 0.26% |
| 2023-06-30 | $0.05B | $5.00B | 0.91% |
| 2023-03-31 | $0.12B | $5.00B | 2.38% |
| 2022-12-31 | $0.55B | $4.94B | 12.85% |
| 2022-09-30 | $0.81B | $4.80B | 23.02% |
| 2022-06-30 | $1.01B | $4.92B | 36.92% |
| 2022-03-31 | $1.01B | $2.42B | 54.46% |
| 2021-12-31 | $0.70B | $1.93B | 43.56% |
| 2021-09-30 | $0.88B | $1.63B | 60.19% |
| 2021-06-30 | $0.90B | $1.41B | 70.75% |
| 2021-03-31 | $0.95B | $1.49B | 88.52% |
| 2020-12-31 | $0.81B | $1.33B | 95.32% |
| 2020-09-30 | $0.37B | $0.85B | 56.51% |
| 2020-06-30 | $0.16B | $0.61B | 26.83% |
| 2020-03-31 | $0.09B | $0.61B | 15.93% |
| 2019-12-31 | $0.07B | $0.56B | 14.14% |
| 2019-09-30 | $0.07B | $0.53B | 15.33% |
| 2019-06-30 | $0.07B | $0.51B | 15.46% |
| 2019-03-31 | $0.07B | $0.46B | 15.82% |
| 2018-12-31 | $0.07B | $0.43B | 19.55% |
| 2018-09-30 | $0.04B | $0.39B | 11.25% |
| 2018-06-30 | $0.02B | $0.37B | 6.98% |
| 2018-03-31 | $0.01B | $0.33B | 4.44% |
| 2017-12-31 | $-0.01B | $0.23B | -4.10% |
| 2017-09-30 | $-0.01B | $0.22B | -2.81% |
| 2017-06-30 | $0.00B | $0.21B | -0.48% |
| 2017-03-31 | $0.00B | $0.22B | 1.48% |
| 2016-12-31 | $-0.01B | $0.20B | -7.10% |
| 2016-09-30 | $-0.01B | $0.20B | -5.95% |
| 2016-06-30 | $-0.01B | $0.19B | -5.79% |
| 2016-03-31 | $-0.01B | $0.20B | -6.00% |
| 2015-12-31 | $-0.01B | $0.22B | -2.61% |
| 2015-09-30 | $0.00B | $0.22B | 0.42% |
| 2015-06-30 | $0.00B | $0.23B | -1.70% |
| 2015-03-31 | $0.00B | $0.25B | -0.86% |
| 2014-12-31 | $-0.01B | $0.25B | -3.53% |
| 2014-09-30 | $-0.01B | $0.22B | -6.32% |
| 2014-06-30 | $-0.01B | $0.22B | -5.41% |
| 2014-03-31 | $-0.01B | $0.23B | -3.16% |
| 2013-12-31 | $0.01B | $0.22B | 3.19% |
| 2013-09-30 | $0.02B | $0.22B | 7.02% |
| 2013-06-30 | $0.02B | $0.22B | 8.74% |
| 2013-03-31 | $0.02B | $0.22B | 8.62% |
| 2012-12-31 | $0.01B | $0.20B | 2.65% |
| 2012-09-30 | $0.00B | $0.19B | -1.62% |
| 2012-06-30 | $0.00B | $0.18B | -1.63% |
| 2012-03-31 | $0.00B | $0.19B | -2.18% |
| 2011-12-31 | $0.01B | $0.19B | 3.83% |
| 2011-09-30 | $0.01B | $0.18B | 3.64% |
| 2011-06-30 | $0.00B | $0.18B | 0.68% |
| 2011-03-31 | $0.00B | $0.18B | 2.29% |
| 2010-12-31 | $-0.01B | $0.11B | -9.54% |
| 2010-09-30 | $0.01B | $0.11B | 7.59% |
| 2010-06-30 | $0.03B | $0.12B | 24.95% |
| 2010-03-31 | $0.03B | $0.12B | 28.39% |
| 2009-12-31 | $0.03B | $0.13B | 29.27% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.948B | $2.783B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.889B | 27.07 |
| Boston Scientific (BSX) | United States | $156.325B | 37.28 |
| Stryker (SYK) | United States | $149.639B | 30.46 |
| EssilorLuxottica (ESLOY) | France | $141.259B | 0.00 |
| Medtronic (MDT) | Ireland | $119.046B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.750B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.937B | 25.13 |
| ResMed (RMD) | United States | $40.192B | 28.75 |
| Agilent Technologies (A) | United States | $35.696B | 23.06 |
| GE HealthCare Technologies (GEHC) | United States | $33.662B | 15.82 |
| Terumo (TRUMY) | Japan | $26.606B | 31.53 |
| Koninklijke Philips (PHG) | Netherlands | $26.557B | 17.57 |
| Insulet (PODD) | United States | $23.925B | 80.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.018B | 13.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.402B | 0.00 |
| Baxter (BAX) | United States | $12.681B | 9.80 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.061B | 29.61 |
| Lantheus Holdings (LNTH) | United States | $3.733B | 10.09 |
| Envista Holdings (NVST) | United States | $3.520B | 24.63 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.349B | 14.86 |
| Perrigo (PRGO) | Ireland | $3.266B | 8.16 |
| ICU Medical (ICUI) | United States | $3.151B | 21.45 |
| Haemonetics (HAE) | United States | $2.628B | 11.73 |
| Acuren (TIC) | United States | $2.261B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.213B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.159B | 46.29 |
| Green Thumb Industries (GTBIF) | United States | $1.840B | 79.00 |
| AtriCure (ATRC) | United States | $1.838B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.519B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.503B | 17.74 |
| AdaptHealth (AHCO) | United States | $1.284B | 18.25 |
| Neogen (NEOG) | United States | $1.249B | 19.83 |
| BioLife Solutions (BLFS) | United States | $1.200B | 2505.00 |
| InMode (INMD) | Israel | $0.944B | 8.74 |
| Kestra Medical Technologies (KMTS) | United States | $0.829B | 0.00 |
| Valneva SE (VALN) | France | $0.753B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.740B | 0.00 |
| SNDL (SNDL) | Canada | $0.704B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.618B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.615B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.52 |
| Evolus (EOLS) | United States | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.479B | 16.50 |
| CeriBell (CBLL) | United States | $0.434B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.432B | 0.00 |
| Owens & Minor (OMI) | United States | $0.379B | 3.36 |
| Sanuwave Health (SNWV) | United States | $0.357B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.352B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.306B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Brainsway (BWAY) | Israel | $0.294B | 59.85 |
| High Tide (HITI) | Canada | $0.292B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.287B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.286B | 21.68 |
| Omeros (OMER) | United States | $0.283B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
| Cerus (CERS) | United States | $0.251B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.242B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.199B | 16.63 |
| FitLife Brands (FTLF) | United States | $0.175B | 0.00 |
| Biote (BTMD) | United States | $0.170B | 5.64 |
| Jushi Holdings (JUSHF) | United States | $0.149B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.111B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.78 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Apyx Medical (APYX) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 33.68 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Veru (VERU) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 31.08 |
| United-Guardian (UG) | United States | $0.039B | 15.02 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Sharps Technology (STSS) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |